After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

(MedPage Today) — WASHINGTON — Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study from…